ホーム › 肺疾患 › マサチューセッツ州 › Boston
Boston、MAにおける肺疾患の臨床試験
Bostonとその周辺地域（約30マイル以内）の拠点で、肺疾患に関する14件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
被験者募集中第3相
- Dana-Farber Cancer Institute, Boston
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
被験者募集中第3相
- Brigham and Women's Hospital, Boston
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
被験者募集中第3相
- Brigham and Women's Hospital, Boston
- Clinical Trials Center, Boston
- Clinical Trials Hub, Boston
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
被験者募集中第2相
- Brigham and Women's Hospital, Boston
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
被験者募集中第1/2相
- Dana Farber Cancer Institute, Boston
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
被験者募集中第3相
- Boston Medical Center, Boston
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
被験者募集中第2相
- Clinical Research Site, Boston
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
被験者募集中第2相
- Beth Israel Deaconess Medical Center, Boston
A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
被験者募集中第2相
- Research Site, Boston
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
被験者募集中第2相
- Dana-Farber Cancer Institute, Boston
- Boston Children's Hospital, Boston
- Brigham and Women's Hospital, Boston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
被験者募集中第1/2相
- Massachusetts General Hospital,, Boston
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
被験者募集中
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
被験者募集中第2相
- Dana-Farber Cancer Institute, Boston
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
被験者募集中
- Brigham and Women's Hospital, Boston
他の都市における肺疾患の試験
- Houston, TX15件の研究
- Durham, NC13件の研究
- New York City, NY12件の研究
- Pittsburgh, PA11件の研究
- Dallas, TX10件の研究
- Nashville, TN10件の研究
- Columbus, OH10件の研究
- Los Angeles, CA10件の研究
- Washington, DC10件の研究
- Miami, FL10件の研究
- Ann Arbor, MI10件の研究
- Chicago, IL9件の研究
Bostonにおける他の研究
- 乳がん111件の研究
- 非小細胞肺癌90件の研究
- がん（全種類）86件の研究
- 大腸癌63件の研究
- 転移性癌63件の研究
- 肺がん62件の研究
- 卵巣がん61件の研究
- 前立腺がん59件の研究
- うつ病52件の研究
- 子宮内膜がん50件の研究
- 心不全44件の研究
- 急性骨髄性白血病44件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。